SOUTH SAN FRANCISCO, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS), a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers, today announced that the company will be presenting at the following upcoming conferences:
Rodman & Renshaw 10th Annual Healthcare Conference
The New York Palace Hotel, New York
Wednesday, November 12, 2008
2:00 p.m. EST
Lazard Capital Markets 5th Annual Healthcare Conference
The St. Regis, New York
Tuesday, November 18, 2008
5:10 p.m. EST
BIO-Europe 2008
m:con Congress Center Rosengarten
Mannheim, Germany
Tuesday, November 18, 2008
9:15 a.m. CET / 3:15 a.m. EST
Interested parties may access a webcast of the Rodman & Renshaw and Lazard Capital presentations by visiting the Sunesis website at http://ir.sunesis.com. A replay of the webcast will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks.
About Sunesis Pharmaceuticals
Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, voreloxin, in multiple indications to improve the lives of people with cancer. For additional information on Sunesis Pharmaceuticals, please visit http://www.sunesis.com.
SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals, Inc.
Contacts: Media Contact:
Sunesis Pharmaceuticals, Inc. Invigorate Communications
Eric Bjerkholt Monique Greer
650-266-3717 415-946-1075
SOURCE Sunesis Pharmaceuticals, Inc.
